SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | +147.4% | 67,754 | +229.1% | 0.02% | +122.2% |
| Q1 2023 | $95 | -73.3% | 20,588 | -53.2% | 0.01% | -79.5% |
| Q4 2022 | $356 | -100.0% | 44,032 | -73.4% | 0.04% | -63.9% |
| Q3 2022 | $919,000 | -19.1% | 165,544 | -24.1% | 0.12% | -28.2% |
| Q2 2022 | $1,136,000 | +290.4% | 218,115 | +515.4% | 0.17% | +335.9% |
| Q1 2022 | $291,000 | -72.6% | 35,442 | -50.4% | 0.04% | -70.9% |
| Q4 2021 | $1,063,000 | – | 71,412 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |